ANALYSIS OF THE PPARD GENE EXPRESSION LEVEL CHANGES IN FOOTBALL PLAYERS IN RESPONSE TO THE TRAINING CYCLE
Domańska-Senderowska D, Snochowska A, Szmigielska P, Jastrzębski Z, Jegier A, Kiszałkiewicz J, Dróbka K, Jastrzębska J, Pastuszak-Lewandoska D, Cięszczyk P, Maciejewska-Skrendo A, Zmijewski P, Brzeziańska-Lasota E
*Corresponding Author: Piotr Zmijewski, Ph.D., Faculty of Medicine, University of Information Technology and Management in Rzeszow, Rzeszow, Poland. Tel: +48-22-384-08-12. Fax: +48-22-835-09-77. E-mail: zmijewski@op.pl
page: 19

REFERENCES

1. Skogsberg J, Kannisto K, Roshani L, Gagné E, Hamsten A, Larsson C, et al. Characterization of the human peroxisome proliferator activated receptor δ gene and its expression. Int J Mol Med. 2000; 6(1): 73-81. 2. N eels JG, Grimaldi PA. Physiological functions of peroxisome proliferator-activated receptor β. Physiol Rev. 2014; 94(3): 795-858. 3. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W. Differential expression of peroxisome proliferatoractivated receptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology. 1996; 137(1): 354-366. 4. Vrins CLJ, van der Velde AE, van den Oever K, Levels JHM, Huet S, Elferink RPJO, et al. Peroxisome proliferator-activated receptor δ activation leads to increased transintestinal cholesterol efflux. J Lipid Res. 2009; 50(10): 2046-2054. 5. Girroir EE, Hollingshead HE, He P. Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice. 2009; 371(3): 456-461. 6. T umova J, Malisova L, Andel M, Trnka J. Protective effect of unsaturated fatty acids on palmitic acid induced toxicity in skeletal muscle cells is not mediated by PPARδ activation. Lipids. 2015; 50(10): 955-964. 7. Briand F. Both the peroxisome proliferator-activated receptor (PPAR) δ agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal re-absorption of HDL-derived cholesterol. 2010; 2(2): 127-133. 8. van der Veen JN, Kruit JK, Havinga R, Baller JFW, Chimini G, Lestavel S, et al. Reduced cholesterol absorption upon PPARδ activation coincides with decreased intestinal expression of NPC1L1. J Lipid Res. 2005; 46(3): 526-534. 9. Muoio DM, MacLean PS, Lang DB, Li S, Houmard JA, Way JM, et al. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR ) α knock-out mice. J Biol Chem. 2002; 277(29): 26089- 26097. 10. G rimaldi PA. Regulatory role of peroxisome proliferator- activated receptor δ (PPARδ) in muscle metabolism. A new target for metabolic syndrome treatment? Biochimie. 2005; 87(1): 5-8. 11. E hrenborg EW, Krook A. Regulation of skeletal muscle physiology and metabolism by peroxisome prolif-erator-activated receptor. Pharmacol Rev. 2009; 61(3): 373-393. 12. Holst D, Luquet S, Nogueira V, Kristiansen K, Leverve X, Grimaldi PA. Nutritional regulation and role of peroxisome proliferator-activated receptor δ in fatty acid catabolism in skeletal muscle. Biochim Biophys Acta. 2003; 1633(1): 43-50. 13. Manickam R, Wahli W. Roles of peroxisome proliferator- activated receptor β/δ in skeletal muscle physiology. Biochimie. 2016; 136: 42-48. 14. N ahlé Z, Hsieh M, Pietka T, Coburn CT, Grimaldi PA, Zhang MQ, et al. CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPARβ/δ-mediated adaptation to metabolic stress. J Biol Chem. 2008; 283(21): 14317-14326. 15. Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M, et al. Peroxisome proliferator-activated receptor δ controls muscle development and oxidative capability. FASEB J. 2003; 17(15): 2299-2301. 16. Wang YX, Zhang CL, Yu RT , Cho HK, Nelson MC, Bayuga-Ocampo CR , et al. Regulation of muscle fiber type and running endurance by PPARδ. PLoS Biol. 2004; 2(10): e294. 17. T anaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, et al. Activation of peroxisome prolif-erator- activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA. 2003; 100(26): 15924-15929. 18. Maciejewska-Karłowska A. Polymorphic variants of the PPAR (peroxisome proliferator-activated receptor) genes: relevance for athletic performance. Trends Sport Sci. 2013; 1(20): 5-15. 19. Mahoney DJ, Parise G, Melov S, Safdar A, Tarnopolsky MA. Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise. FASEB J. 2005;19(11):1498-1500. 20. Radzimiński Ł, Rompa P, Dargiewicz R, Ignatiuk W, Jastrzębski Z. An application of incremental running test results to train professional soccer players. An Application of Incremental Running Test Results to Train Professional Soccer Players. Baltic J Health Phys Act. 2010; 2(1): 67-74 (http://bjhpa.journalstube. com/view/abstract/ id/10444). 21. Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol Rev. 2006; 86(2): 465-514. 22. Yessoufou A, Wahli W. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. Swiss Med Wkly. 2010; 140: w13071. 23. E gan B, Zierath JR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 2013; 17(2): 162-184. 24. Hawley JA, Hargreaves M, Joyner MJ, Zierath JR. Integrative biology of exercise. Cell. 2014; 159(4): 738-749. 25. E gan B, Hawley JA, Zierath JR. SnapShot: Exercise metabolism. Cell Metab. 2016; 24(2): 342-342.e1. doi: 10.1016/j.cmet.2016.07.013. 26. Wahli W, Michalik L. PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metab. 2012; 23(7): 351-363. 27. C hawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: Opening the X-files. Science. 2001; 294(5548): 1866-1870. 28. Perry CGR, Lally J, Holloway GP, Heigenhauser GJF, Bonen A, Spriet LL. Repeated transient mRNA bursts precede increases in transcriptional and mitochondrial proteins during training in human skeletal muscle. J Physiol. 2010; 588(23): 4795-4810. 29. R ussell AP, Hesselink MK, Lo SK, Schrauwen P. Regulation of metabolic transcriptional co-activators and transcription factors with acute exercise. FASEB J. 2005; 19(8): 986-988. 30. E rol A. Muscle-specific PPARβ/δ agonism may provide synergistic benefits with life style modifications. PPAR Res. 2007; 2007: 30578. doi: 10.1155/2007/30578. 31. Pérez-Schindler J, Svensson K, Vargas-Fernández E, Santos G, Wahli W, Handschin C. The coactivator PGC-1α regulates skeletal muscle oxidative metabolism independently of the nuclear receptor PPARβ/δ in sedentary mice fed a regular chow diet. Diabetologia. 2014; 57(11): 2405-2412. 32. Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, Muscat GEO. The peroxisome proliferator-activated receptor β/δ agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol. 2003; 17(12): 2477-2493. 33. Wang YX, Lee CH, Tiep S, Yu RT , Ham J, Kang H, et al. Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell. 2003; 113(2): 159-170. 34. Moldoveanu AI, Shephard RJ, Shek PN. The cytokine response to physical activity and training. Sports Med. 2001; 31(2): 115-144. 35. Baskin KK, Winders BR, Olson EN. Muscle as a “mediator” of systemic metabolism. Cell Metab. 2015; 21(2): 237-248. 36. T rejo-Gutierrez JF, Fletcher G. Impact of exercise on blood lipids and lipoproteins. J Clin Lipidol. 2007; 1(3): 175-181. 37. Monda KL, Ballantyne CM, North KE. Longitudinal impact of physical activity on lipid profiles in middleaged adults: The Atherosclerosis Risk in Communities Study. J Lipid Res. 2009; 50(8): 1685-1691. 38. Silva RC, Diniz Mde F, Alvim S, Vidigal PG, Fedeli LM, Barreto SM. Physical activity and lipid profile in the ELSA-Brasil study. Arq Bras Cardiol. 2016; 107(1): 10-19. 39. A lderete TL, Gyllenhammer LE, Byrd-Williams CE, Spruijt-Metz D, Goran MI, Davis JN. Increasing physical activity decreases hepatic fat and metabolic risk factors. J Exerc Physiol Online. 2013; 15(2): 40-54. 40. Schrauwen P, Westerterp KR. The role of high-fat diets and physical activity in the regulation of body weight. Br J Nutr. 2000; 84(4): 417-427. 41. Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, et al. Cardiomyocyte-restricted peroxisome proliferator- activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med. 2004; 10(11): 1245-1250.



Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Accepted articles (Accepted, unedited articles, published online and can be cited. The final edited and printed version of the manuscript will appear in future)
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006